These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31917867)

  • 21. Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy.
    Giri D; Price V; Yung Z; Didi M; Senniappan S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):347-50. PubMed ID: 27087264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital hyperinsulinism due to mutations in HNF1A.
    Yau D; Colclough K; Natarajan A; Parikh R; Canham N; Didi M; Senniappan S; Banerjee I
    Eur J Med Genet; 2020 Jun; 63(6):103928. PubMed ID: 32325224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital Hyperinsulinism Caused by Novel Homozygous KATP Channel Gene Variants May Be Linked to Unexplained Neonatal Deaths among Kurdish Consanguineous Families.
    Amaratunga SA; Hussein Tayeb T; Rozenkova K; Kucerova P; Pruhova S; Lebl J
    Horm Res Paediatr; 2020; 93(1):58-65. PubMed ID: 32203961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8.
    Apperley L; Giri D; Houghton JAL; Flanagan SE; Didi M; Senniappan S
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):301-304. PubMed ID: 30730840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and Emerging Agents for the Treatment of Hypoglycemia in Patients with Congenital Hyperinsulinism.
    De Cosio AP; Thornton P
    Paediatr Drugs; 2019 Jun; 21(3):123-136. PubMed ID: 31218604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact.
    Shah P; Rahman SA; McElroy S; Gilbert C; Morgan K; Hinchey L; Senniappan S; Levy H; Amin R; Hussain K
    Horm Res Paediatr; 2015; 84(5):355-60. PubMed ID: 26375451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary strategies in the diagnosis and management of neonatal hyperinsulinaemic hypoglycaemia.
    Lindley KJ; Dunne MJ
    Early Hum Dev; 2005 Jan; 81(1):61-72. PubMed ID: 15707716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical management of medically-refractory hyperinsulinism.
    Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE
    Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term lanreotide treatment in six patients with congenital hyperinsulinism.
    Kühnen P; Marquard J; Ernert A; Meissner T; Raile K; Wannenmacher G; Blankenstein O
    Horm Res Paediatr; 2012; 78(2):106-12. PubMed ID: 22907123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success.
    Szymanowski M; Estebanez MS; Padidela R; Han B; Mosinska K; Stevens A; Damaj L; Pihan-Le Bars F; Lascouts E; Reynaud R; Ferreira C; Bansept C; de Lonlay P; Saint-Martin C; Dunne MJ; Banerjee I; Arnoux JB
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4719-4729. PubMed ID: 27691052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases.
    de Lonlay P; Fournet JC; Touati G; Groos MS; Martin D; Sevin C; Delagne V; Mayaud C; Chigot V; Sempoux C; Brusset MC; Laborde K; Bellane-Chantelot C; Vassault A; Rahier J; Junien C; Brunelle F; Nihoul-Fékété C; Saudubray JM; Robert JJ
    Eur J Pediatr; 2002 Jan; 161(1):37-48. PubMed ID: 11808879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.
    Welters A; Lerch C; Kummer S; Marquard J; Salgin B; Mayatepek E; Meissner T
    Orphanet J Rare Dis; 2015 Nov; 10():150. PubMed ID: 26608306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of hypoglycaemia on neurocognitive outcome in children and adolescents with transient or persistent congenital hyperinsulinism.
    Muukkonen L; Männistö J; Jääskeläinen J; Hannonen R; Huopio H
    Dev Med Child Neurol; 2019 Apr; 61(4):451-457. PubMed ID: 30246438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electroencephalogram features in children with congenital hyperinsulinism treated according to the international protocol in Russian Federation].
    Sarakaeva LR; Ryzhkova DV; Mitrofanova LB; Bairov VG; Sukhotskaya AA; Smorodin AP; Eftich EA; Kelmanson IA; Nikitina IL
    Probl Endokrinol (Mosk); 2023 Feb; 69(1):68-75. PubMed ID: 36842080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy.
    Minute M; Patti G; Tornese G; Faleschini E; Zuiani C; Ventura A
    Pediatrics; 2015 Nov; 136(5):e1373-6. PubMed ID: 26504125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism.
    Levy-Shraga Y; Pinhas-Hamiel O; Kraus-Houminer E; Landau H; Mazor-Aronovitch K; Modan-Moses D; Gillis D; Koren I; Dollberg D; Gabis LV
    J Pediatr Endocrinol Metab; 2013; 26(3-4):301-8. PubMed ID: 23327786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible New Strategies for the Treatment of Congenital Hyperinsulinism.
    Sikimic J; Hoffmeister T; Gresch A; Kaiser J; Barthlen W; Wolke C; Wieland I; Lendeckel U; Krippeit-Drews P; Düfer M; Drews G
    Front Endocrinol (Lausanne); 2020; 11():545638. PubMed ID: 33193079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.